Senior Scientist Viral Gene Therapy | Senior Scientist Viral Gene Therapy (all genders)
Merck KGaA
Job Summary
This role seeks a Senior Scientist to join the Patient Centric Formulation Team within Excipients R&D, focusing on viral gene therapy applications. The successful candidate will lead the establishment of innovative capabilities for studying virus stability and optimizing analytical methods specifically for viral vectors, such as Adeno-Associated Viruses (AAVs). Day-to-day activities include designing and executing complex experiments, performing assays for thorough formulation characterization, and interpreting data to guide product development. The position requires strong independence, exceptional communication skills for presenting findings to global, interdisciplinary scientific, management, and commercial audiences, and mandatory experience with AAVs. This is an exciting opportunity to drive innovation in Life Science R&D and collaborate across diverse, global departments.
Required Skills
Education
PhD in Virology, Biology, Biochemistry, or a related discipline
Experience
- Initial working experience as a Postdoctoral Researcher or in a comparable role
- Mandatory experience with Adeno-Associated Viruses (AAVs)
- Experience in formulation development (ideal)
- Proven ability to work independently and collaboratively
Languages
Additional
- Not specified
More Jobs from Merck KGaA
Proteomics Bench Scientist | Proteomics Bench Scientist (all genders) Full-Time/Part-Time
Jan 19, 2026
This role is for an experienced Bench Scientist to join the Site Management Analytics team, acting a...
Senior Director, Real World Data Methodologies and Solutions | Senior Director, Real World Data Methodologies and Solutions (all genders)
Jan 19, 2026
This Senior Director role is seeking a Team Head to lead the strategy, partnerships, methodologies, ...
Senior Toxicologist | Senior Toxicologist (all genders)
Jan 14, 2026
The Senior Toxicologist will join the Nonclinical Safety Global Project Strategy and Science (PSS) t...